Newsfeeds - Spark Newswire

1 minute read

Glaukos Q4 EPS $(0.31) Beats $(0.37) Estimate, Sales $73.24M Beat $67.28M Estimate

Today, 4:09 PM

Glaukos (NYSE:GKOS) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.37) by 16.22 percent. This is a 1450 percent decrease over losses of $(0.02) per share from the same

GKOS

11 minute read

Earnings Scheduled For February 22, 2022

By Benzinga Insights

Today, 4:09 PM

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million.

4 minute read

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow

By Shanthi Rexaline

Today, 4:09 PM

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.

ABCL

4 minute read

Glaukos Names Joseph Gilliam Pres, COO

By Benzinga Newsdesk

Today, 4:09 PM

Glaukos Corporation (NYSE:GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced several

GKOS

5 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For February 3, 2022

By Benzinga Insights

Today, 4:09 PM

AEM

18 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For January 19, 2022

By Benzinga Insights

Today, 4:09 PM

Upgrades

ABB

1 minute read

Wells Fargo Upgrades Glaukos to Equal-Weight, Announces $56 Price Target

By Benzinga Newsdesk

Today, 4:09 PM

Wells Fargo analyst Lawrence Biegelsen upgrades Glaukos (NYSE:GKOS) from Underweight to Equal-Weight and announces $56 price target.

GKOS

4 minute read

Options

10 Health Care Stocks With Whale Alerts In Today’s Session

By Benzinga Insights

Today, 4:09 PM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

ACAD